Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/10/2008

-------------------

Net income (loss) 4,577 (1,930) 752 (6,313)

Redeemable convertible

preferred share accretion 417 735 1,973 2,156

------------------- -------------------

Income (loss) attributable to

common shareholders $ 4,160 $ (2,665) $ (1,221) $ (8,469)

------------------- -------------------

------------------- -------------------

Condensed Balance Sheets

(in thousands)

September 30, December 31,

2008 2007

(unaudited)

Assets:

Cash, cash equivalents and short

term investments $ 17,178 $ 5,131

Amounts and investment tax credit

receivable 1,375 1,813

Prepaid and other current assets 1,129 295

Property, equipment and other assets 566 111

----------------------------

Total assets $ 20,248 $ 7,350

----------------------------

----------------------------

Liabilities and stockholders' equity:

Accounts payable and accrued expenses $ 2,700 $ 1,048

Other current liabilities 905 4,665

Long term liabilities 1,163 2,487

Redeemable convertible preferred shares - 37,373

Stockh
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual list of the ... 1,361 in growth for the three years through 2014. Being named to the Inc. ... organizations in the country. , “We are thrilled to make the Inc. 5000 ...
(Date:8/27/2015)... RESEARCH TRIANGLE PARK, N.C. , Aug. 27, ... reports on the decision by FedEx, UPS and ... shipments of certain biological specimens classified as ,select ... expertise and long history of handling these sensitive ... network, knowledge of global transportation regulations, trained and ...
(Date:8/26/2015)... ... August 26, 2015 , ... ... that a second US laboratory is to open in Manhattan, Kansas in early ... partnership and long-term growth of research and development through collaboration with researchers from ...
(Date:8/26/2015)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... the detection of foodborne pathogens, today announced that Paul ... Company Emerging Growth Conference on September 2 at 9:20am ... York Marriott Marquis. A live webcast ... relations section of Roka Bioscience,s website at http://rokabio.investorroom.com/ ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Marken Ensures Safe Transportation Of Select Agents And Toxins 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3
... biotechnology,company developing clinical stage treatments for cancer and the ... CEO, is scheduled to present at the UBS Global ... The conference is being held at,the Grand Hyatt New ... BioVex is a privately held biotechnology Company based in ...
... is featured speaker: "Case Study - Screening Ion Channels ... Safety and Efficacy" on Friday, September 26 at 11:30, ... expanding,line of ion channel services and cell lines for ... and Cellular Targets,conference in San Diego, September 24-26. ChanTest ...
... BioTrends Research Group, Inc.,released its third annual ... providing insight into the management of,Rheumatoid Arthritis (RA), ... is based on responses to an online survey,completed ... According to the study, the majority of Rheumatologists ...
Cached Biology Technology:BioVex to Present at the UBS Global Life Sciences Conference 2ChanTest to Highlight the World's Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11 2Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis? 2
(Date:7/31/2015)... julio de 2015 La 10 th International ... medio de BGI del 22 al 25 de octubre de 2015 ... Este año, la conferencia celebra su décimo aniversario. Desde su ... una de las reuniones anuales más influyentes del mundo en ... más dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/31/2015)... China , July 31, 2015 The 10 ... will be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th anniversary ... one of the world,s most influential annual meetings in the ... and enjoyable scientific gatherings. ICG-10 focuses on ...
(Date:7/27/2015)... ANGELES , July 27, 2015   ... evidence- and experience-based clinical improvement solutions, today announced ... solution is now available on Android smartphones and ... inpatient and post-care organizations can use ZynxCarebook to ... same patient,s condition, streamline care transitions to other ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... first workshop on male infertility in Thessaloniki, Greece "Reproductive ... workshop provides a forum for clinicians and scientists to ... Here some of the new research findings that fertility ... Nature versus Nurture: Male reproductive disorders ...
... State University is being honored for one of its ... K-State institute,s intern program has received the roundtable group,s ... MVP2 award, as the best pollution prevention project/program. The ... D.C. The award is presented based on a ...
... b3c newswire / - NiKem Research is pleased ... of Health, GLP certification of its bioanalysis facilities to further ... provided for many years high quality cost-effective bioanalytical support both ... in vivo PK services associated to various drug discovery ...
Cached Biology News:K-State Pollution Prevention Institute's intern program named best 2NiKem Research receives certification for GLP Bioanalysis 2
96 Well Plate UB, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
96 Well Plate EB, RE bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes. Guaranteed coefficient of variation (CVs)....
Immulon 1 B 1x12 Strip, flat bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
...
Biology Products: